Breakthrough Case Management Team to be supported by Breathlab Course
Case managers at Breakthrough are being supported with their mental [...]
Daily News Round Up: Wednesday, 20 March
Welcome to your daily round-up of everything happening in the world of neurorehabilitation.
Research news
Greater access to legal aid for injury victims
People who have experienced injury, personal harm, or miscarriages of [...]
New Parkinson’s drug shows positive results in preclinical studies
IRLAB’s drug mesdopetam has displayed antipsychotic properties in an advanced model of Parkinson’ s disease psychosis (PD-P).
Discover: - IRLAB's preclinical results from mesdopetam in an advanced preclinical model of PD-P - Mesdopetam's potential as a novel therapeutic in PD-P - The role of the dopamine D3 receptor in PD-P
Brotherwood WAV & Mobility Show returns with new format this May
The Brotherwood WAV Show is to return to Haynes Motor [...]
Daily News Round Up: Tuesday, 19 March
Welcome to your daily round-up of everything happening in the world of neurorehabilitation.
Research news
Alzheimer's drug presents unique challenge for patients with cardiovascular disease
Calvert Reconnections hosts latest open day
Law firm Stewarts and rehab specialists STEPS were the latest [...]
Havana Syndrome: no evidence of MRI-detectable brain injury or biological abnormalities
A new study has revealed that US government personnel who [...]
Understanding brain stimulation therapies
A new study has revealed for the first time how [...]
